Family history and risk of venous thromboembolism with oral contraception : Family history is important tool

Por Vandenbroucke, Jan P, van der Meer, Felix J M, Helmerhorst, Frans M, Rosendaal, Frits R
Publicado em 2001

Vitamin K(1) supplementation to improve the stability of anticoagulation therapy with vitamin K antagonists: a dose-finding study

Por Gebuis, Edward P.A., Rosendaal, Frits R., van Meegen, Erik, van der Meer, Felix J.M.
Publicado em 2011

Objectives and Design of BLEEDS: A Cohort Study to Identify New Risk Factors and Predictors for Major Bleeding during Treatment with Vitamin K Antagonists

Por van Rein, Nienke, Lijfering, Willem M., Bos, Mettine H. A., Herruer, Martien H., Vermaas, Helga W., van der Meer, Felix J. M., Reitsma, Pieter H.
Publicado no PLoS One (2016)

Recurrence risk after anticoagulant treatment of limited duration for late, second venous thromboembolism

Por van der Hulle, Tom, Tan, Melanie, den Exter, Paul L., van Roosmalen, Mark J.G., van der Meer, Felix J.M., Eikenboom, Jeroen, Huisman, Menno V., Klok, Frederikus A.
Publicado no Haematologica (2015)

The HAS-BLED Score Identifies Patients with Acute Venous Thromboembolism at High Risk of Major Bleeding Complications during the First Six Months of Anticoagulant Treatment

Por Kooiman, Judith, van Hagen, Nadja, Iglesias del Sol, Antonio, Planken, Erwin V., Lip, Gregory Y. H., van der Meer, Felix J. M., Cannegieter, Suzanne C., Klok, Frederikus A., Huisman, Menno V.
Publicado no PLoS One (2015)

The effect of omeprazole and esomeprazole on the maintenance dose of phenprocoumon

Por Verhoef, Talitha I, Zuurhout, Miranda J L, van Schie, Rianne M F, Redekop, William K, van der Meer, Felix J M, le Cessie, Saskia, Schalekamp, Tom, de Boer, Anthonius, Maitland-van der Zee, Anke Hilse
Publicado em 2012